• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


| Print

Cellectis SA (CLLS)

American Depository Receipt
Sell: $3.15|Buy: $3.99|Change: 0.02 (-0.64%)

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP

Company profile

Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.

Address

8 rue de la Croix Jarry
Paris
FRA
75013

Website

https://www.cellectis.com

Sector 

Healthcare

Forecast key dates

NameKey Date
Cellectis SA Second Quarter Earnings Results for 20272027-08-06T00:00:00
Cellectis SA Annual General Meeting for 20262027-06-25T14:30:00
Cellectis SA First Quarter Earnings Results for 20272027-05-11T00:00:00
Cellectis SA Fourth Quarter Earnings Conference Call for 20262027-03-19T08:00:00
Cellectis SA Fourth Quarter Earnings Results for 20262027-03-19T00:00:00
Cellectis SA Annual Report for 20262027-03-19T00:00:00
Jefferies Global Healthcare Conference2026-11-16T00:00:00
Stifel 2026 Healthcare Conference2026-11-10T00:00:00
Cellectis SA Third Quarter Earnings Results for 20262026-11-06T00:00:00
2026 Baird’s Global Healthcare Conference2026-09-15T12:50:00
Wells Fargo 21st Annual Healthcare Conference2026-09-10T00:00:00

Previous key dates

NameKey Date
2026 Baird’s Global Healthcare Conference2026-09-15T12:50:00
Wells Fargo 21st Annual Healthcare Conference2026-09-10T00:00:00
Cellectis SA Second Quarter Earnings Results for 20262026-08-06T00:00:00
Cellectis SA Annual General Meeting for 20252026-06-25T14:30:00
Cellectis SA First Quarter Earnings Results for 20262026-05-11T00:00:00
Cellectis SA Fourth Quarter Earnings Conference Call for 20252026-03-20T08:00:00
Cellectis SA Annual Report for 20252026-03-20T00:00:00
Cellectis SA Fourth Quarter Earnings Results for 20252026-03-19T00:00:00
Cellectis SA Third Quarter Earnings Results for 20252025-11-07T00:00:00
PSCC Ecosystem Breakfast2025-11-04T07:45:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2026 AJ Bell. All rights reserved.